Joint Formulary & PAD

Tramadol hydrochloride - Pain (Neuropathic)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Capsules
  • Soluble tablets
Associated Icons :
BNF SPC
CD
Restrictions / Comments :
 

Status 2

Green (see narrative)
Formulations :
  • Modified release capsules
  • Modified release tablets
Associated Icons :
BNF SPC
CD
Restrictions / Comments :
Important
MR preparations to be prescribed by brand. Marol MR tablets are the locally preferred brand for primary care.

PAD Profile

ChemicalSubstance :
Tramadol hydrochloride
Indication :
Pain (Neuropathic)
Group Name :
Keywords :
neuropathic pain, diabetic neuropathy, postherpetic neuralgia, PHN
Brand Names Include :
Marol
Important Information :
NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Tramadol hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pain (Neuropathic).

Committee Recommendations (1)

Tramadol may be considered for patients awaiting referral to pain specialist, after initial treatments have failed. See neuropathic pain guidelines below.

Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.

PLEASE NOTE:
Standard/Immediate release capsules should be prescribed GENERICALLY
Modified release tablets should be prescribed by BRAND with Marol® being locally preferred